Rakshith Rangarajan, Equity Fund Manager, Inviga Investment Advisors Private Limited.

For years, India’s healthcare conversation has been dominated by a familiar cast of metros:
Chennai, Bengaluru, Hyderabad. Yet the most interesting part of the story is now unfolding a
tier below, in cities like Coimbatore, Madurai, Tiruchirappalli, Mangaluru, and
Hubballi–Dharwad. These are not sleepy provincial outposts. They are dense, fast-growing
service economies with rising non-communicable disease burdens, robust private sectors,
and increasingly assertive patients.

South India starts from a structurally different base. Kerala, Tamil Nadu, and Telangana sit
at or near the top of successive NITI Aayog health-index rankings, with Karnataka not far
behind. These rankings reflect decades of investment in education, primary care, and
institutional delivery, layered over relatively effective state machinery and strong private
participation. The result is a long-running virtuous cycle: educated populations, early public-
health gains, dense medical-education capacity, and a large private footprint, all reinforcing
each other.

In that context, South India’s Tier-2 cities are starting to function as regional health systems
in their own right, not merely feeders to the metros.
A southern advantage built over decades
Southern states host a disproportionately high share of India’s medical colleges, particularly
in the private sector. That matters less as a bragging right and more as a practical source of
human capital: more doctors, specialists, and nurses per capita, and a deeper bench willing
to live and work in smaller cities. This training ecosystem anchors tertiary centers and makes
it structurally easier to sustain higher-end services in Tier-2 locations.

At the same time, early investments in maternal and child health, immunization, and family
planning produced better outcomes and higher life expectancy than national averages.
Higher literacy and health awareness translate into earlier care-seeking, greater acceptance
of institutional care, and more informed demand for quality. Patients are quicker to challenge
poor service, and quicker to reward hospitals that behave like serious institutions rather than
glorified nursing homes.

Layer on a long history of private investment in both hospitals and medical education, and
South India looks less like a patchwork of isolated facilities and more like a set of hybrid
ecosystems. Public and private sectors coexist; competition, referral linkages, and patient
expectations have collectively raised the baseline standard of care.
Prototype hubs: Coimbatore, Madurai, Mangaluru, Hubballi
Within this landscape, a handful of Tier-2 cities have emerged as “prototype hubs”.

Coimbatore is one of the clearest examples: an industrial and educational city with an
international airport, Gulf connectivity, and a catchment that spans western Tamil Nadu and
parts of Kerala. It already hosts multiple tertiary hospitals and diagnostic chains, yet its mid-
market remains fragmented. There is ample room for 100–200-bed hospitals that bring Tier-
1-style governance and protocols to middle-income neighbourhoods and peripheral suburbs.
Madurai and Tiruchirappalli play similar roles in southern and central Tamil Nadu. Both have
functioning airports, large migrant and diaspora links, and broad catchments reaching into
multiple districts. They are rich in mission, trust, and corporate hospitals, but patients still

travel to Chennai or Coimbatore for certain specialties and higher-acuity services. That
pattern of partial self-sufficiency with visible leakage suggests strong potential for focused,
protocol-driven mid-sized hospitals in rapidly urbanizing corridors around the core cities.
On the western coast, Mangaluru leverages an international airport, Konkan road and rail
links, and a dense cluster of medical and nursing colleges. It pulls patients from coastal
Karnataka, northern Kerala, and interior coffee country for complex surgery, cardiac care,
and oncology. Here too, services are concentrated in a few large campuses; there is white
space for mid-sized multi-specialty hospitals in peripheral taluks and for satellite facilities tied
more tightly into primary and secondary care.

Hubballi–Dharwad is a different kind of prototype: an emerging commercial and educational
hub for North Karnataka, with growing air connectivity and a catchment that extends into
southern Maharashtra and even Goa for certain services. Historically, complex cardiac and
oncology cases moved almost by default to Bengaluru or Pune. Recent investments have
begun to reverse some of this outflow, but general multi-specialty capacity beyond a handful
of large institutions remains uneven. That makes 100–150-bed high-acuity hospitals
particularly viable.

Across these cities, the common pattern is simple: airport connectivity sufficient to move
specialists and patients, sizeable multi-district catchments with rising non-communicable
disease burdens and paying power, partial but not saturated tertiary ecosystems, and
ongoing out-migration of complex cases. These are precisely the conditions in which the
next wave of well-run Tier-2 hospitals can be both impactful and profitable.
Ecosystems, not stand-alone hospitals
In these hubs, the symbiotic relationship between private hospitals and the local
ecosystem—medical colleges, nursing schools, local MedTech manufacturers and
distributors—is not a “nice to have”. It is structurally critical.

Medical and nursing colleges provide the talent pipeline needed to run 24/7 emergency, ICU,
and operative services without relying entirely on imports from metros. Teaching hospitals
and established centers raise the bar on case complexity, making it easier for smaller and
mid-sized hospitals to plug into referral networks, share visiting consultants, run joint clinics,
and host DNB programs. In Coimbatore and Mangaluru, dense clusters of colleges and an
emerging MedTech base create quasi-clusters where hospitals can access trained staff,
research collaborators, and early access to devices and diagnostics tailored to Tier-2 price
points. In Hubballi–Dharwad, partnerships for training and continuous education are often
the only way to lock in a sustainable workforce and justify adding beds.

Where these links are tight—through training tie-ups, device pilots, and shared referral
pathways—hospitals scale faster, with lower clinical risk and more predictable economics.
Where they are weak, even well-capitalized projects struggle. Beds get built; quality talent,
appropriate technology, and stable demand do not follow at the same pace.
From distressed city hospital to regional anchor
Prototype for a Tier-2 Hospital Turnaround (a real-world case study)
A distressed 250-bed, doctor-promoted hospital in a prominent North Karnataka hub serves
as a template for how capital and governance can unlock regional healthcare value. A
decade ago, the asset was in crisis: burdened by ₹120 crore in debt, it suffered from
stagnant 30% occupancy and negative EBITDA on revenues of ₹30 crore.

The turnaround, led by a control-oriented buyout, involved a comprehensive reset:
Capital & Structure: New equity was injected at a discount, debt was restructured, and
promoter doctors were re-aligned around departmental ownership.
Operational Rigor: Governance, cost discipline, and clinical throughput were
institutionalized through a focused operating program.

Performance Swing: Within five years, revenues climbed to ₹80 crore, EBITDA turned
significantly positive, and occupancy surged past 70%.
By stabilizing the balance sheet and professionalizing management, the facility evolved from
a struggling city clinic into a default tertiary anchor for the surrounding region, capturing
complex cases that previously migrated to metros like Bengaluru or Pune. Variations of this
story are now possible in multiple Tier-2 hubs that share similar catchments, balance-sheet
stress, and ecosystem advantages.

Patients as Pragmatic Adopters and Tier-2 as Test Bed
Patient behavior in these cities is changing in ways that favor credible local platforms. While
smartphone and data penetration are high, Tier-2 patients are not chasing every new app;
they prefer hospital-anchored, vernacular, low-friction digital journeys that clearly save time
and money. In one of the Tier-2 hubs within our ecosystem, for example, over 50% of follow-
up consultations for stable chronic patients have shifted to hospital-anchored teleconsults or
structured WhatsApp-style OPDs. This shift has significantly reduced no-show rates and
travel burdens without eroding clinical trust, as the patient knows the digital interface is
backed by a physical facility they can visit if needed.

Prevention follows a similarly pragmatic pattern. Post-COVID, families are more willing to
pay for periodic health checks or targeted screenings for diabetes, hypertension, and cancer
risk—but only when pricing is transparent, and the link to avoided risk is explicit. “Defensive
prevention”—spending modestly now to avoid catastrophic hospitalization later—trumps
lifestyle wellness. This combination makes South India’s Tier-2 cities ideal test beds for
“India-fit” hardware–software combinations. Hospitals and diagnostic chains here pilot mid-
tier imaging and point-of-care technologies that must prove themselves on clinical
performance.

This combination makes South India’s Tier-2 cities ideal test beds for “India-fit”
hardware–software combinations. Hospitals and diagnostic chains pilot mid-tier imaging,
point-of-care, and ICU technologies that must prove themselves on clinical performance,
ruggedness,s and affordability simultaneously. Digital-health firms test vernacular telehealth,
chronic-care programs, and outcome-linked pricing in markets that are demanding enough to
be credible and price-sensitive enough to kill bad ideas quickly.

The Investment Lens: Building for Scale and Exit
From a fund manager’s perspective, the most compelling opportunities in this geography are
75–250 bed regional anchors and specialized ambulatory networks that can be tied to
these hubs. Our entry logic focuses on identifying underperforming but strategically located
Tier-2 assets where we can apply a “battle-tested” operating playbook—driving EBITDA
expansion through occupancy mix optimization and institutionalizing gov-tech upgrades.
By professionalizing these standalone facilities into a cohesive regional platform, we create a
clear pathway for exit via strategic roll-ups by national chains or through a public listing,
tapping into the premium multiples that high-quality, scaled healthcare assets command.

A ten-year view
Look ahead a decade, and it is not hard to imagine what a self-sustaining Tier-2 ecosystem
in South India could look like. Each hub city would have two or three NABH-grade multi-
specialty hospitals with robust emergency, ICU, obstetrics, pediatrics, orthopedic trauma,
general surgery, and internal medicine; layered on top, a handful of focused centers of
excellence in high-burden specialties such as cardiology, oncology or neuro-trauma; and a
network of day-care and ambulatory centers handling high-volume procedures efficiently.

Diagnostics, devices,s and digital rails would be fully embedded: advanced imaging, cath
labs where justified, strong regional lab hubs with satellite collection networks, and Make-in-
India devices feeding interoperable hospital systems and personal health records. Medical
colleges and nursing schools would be tightly partnered with hospitals via residencies, DNB
seats, and nurse-residency programs, ensuring a steady supply of specialists and senior
nurses who actually want to build careers locally. Public schemes such as Ayushman Bharat
PM-JAY—which already promises ₹5 lakh of cover per poor household for secondary and
tertiary care—along with private insurers and employers would contract on value, steering
patients to these Tier-2 networks for all but the most complex cases.

In that world, South Indian Tier-2 ecosystems should be able to manage 70–80 percent of
today’s metro-referred cases locally, sending only the top 20–30 percent of ultra-complex
work to Chennai, Bengaluru, or Hyderabad.

The striking point is that much of the necessary scaffolding already exists. The question now
is whether operators, investors, and policymakers are prepared to treat these cities not as
peripheral markets but as the places where India’s next decade of healthcare innovation will
actually be built and tested.